25 XP   0   0   10

CSPC Pharmaceutical Group Ltd
Buy, Hold or Sell?

Let's analyse Cspc together

PenkeI guess you are interested in CSPC Pharmaceutical Group Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CSPC Pharmaceutical Group Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about CSPC Pharmaceutical Group Ltd

I send you an email if I find something interesting about CSPC Pharmaceutical Group Ltd.

Quick analysis of Cspc (30 sec.)










What can you expect buying and holding a share of Cspc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
$0.41
Expected worth in 1 year
$0.53
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$0.12
Return On Investment
15.9%

For what price can you sell your share?

Current Price per Share
$0.75
Expected price per share
$0.75 - $
How sure are you?
50%

1. Valuation of Cspc (5 min.)




Live pricePrice per Share (EOD)

$0.75

2. Growth of Cspc (5 min.)




Is Cspc growing?

Current yearPrevious yearGrowGrow %
How rich?$4.9b$4.5b$349.6m7.1%

How much money is Cspc making?

Current yearPrevious yearGrowGrow %
Making money$114.6m$125.1m-$10.4m-9.1%
Net Profit Margin18.7%19.7%--

How much money comes from the company's main activities?

3. Financial Health of Cspc (5 min.)




What can you expect buying and holding a share of Cspc? (5 min.)

Welcome investor! Cspc's management wants to use your money to grow the business. In return you get a share of Cspc.

What can you expect buying and holding a share of Cspc?

First you should know what it really means to hold a share of Cspc. And how you can make/lose money.

Speculation

The Price per Share of Cspc is $0.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cspc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cspc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.41. Based on the TTM, the Book Value Change Per Share is $0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cspc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.011.3%0.011.3%0.011.4%0.045.0%0.034.2%
Usd Book Value Change Per Share0.034.0%0.034.0%0.033.9%-0.18-23.5%-0.02-3.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.5%0.000.3%0.000.6%
Usd Total Gains Per Share0.034.0%0.034.0%0.034.4%-0.17-23.2%-0.02-2.3%
Usd Price Per Share0.80-0.80-1.01-0.77-0.53-
Price to Earnings Ratio83.05-83.05-96.20-42.36-25.24-
Price-to-Total Gains Ratio26.78-26.78-30.50-22.44-19.21-
Price to Book Ratio1.93-1.93-2.62-2.15-1.19-
Price-to-Total Gains Ratio26.78-26.78-30.50-22.44-19.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.75
Number of shares1333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.03-0.18
Usd Total Gains Per Share0.03-0.17
Gains per Quarter (1333 shares)39.81-231.65
Gains per Year (1333 shares)159.26-926.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1015914912-938-937
2031930823-1876-1864
3047846735-2814-2791
4063762646-3752-3718
5079678558-4691-4645
6095694469-5629-5572
701115110381-6567-6499
801274126292-7505-7426
9014331421104-8443-8353
10015931580115-9381-9280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%10.00.01.090.9%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%

Fundamentals of Cspc

About CSPC Pharmaceutical Group Ltd

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company has a strategic partnership with Pfizer Inc. to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-11 16:44:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.

1.1. Profitability of CSPC Pharmaceutical Group Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cspc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 18.7% means that $0.19 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 18.7%. The company is making a huge profit. +2
  • The TTM is 18.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.7%TTM18.7%0.0%
TTM18.7%YOY19.7%-1.0%
TTM18.7%5Y19.2%-0.5%
5Y19.2%10Y17.4%+1.7%
1.1.2. Return on Assets

Shows how efficient Cspc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • 1.8% Return on Assets means that Cspc generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY2.1%-0.3%
TTM1.8%5Y2.1%-0.3%
5Y2.1%10Y1.9%+0.1%
1.1.3. Return on Equity

Shows how efficient Cspc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • 2.4% Return on Equity means Cspc generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 2.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.4%0.0%
TTM2.4%YOY2.9%-0.4%
TTM2.4%5Y2.8%-0.4%
5Y2.8%10Y2.8%+0.1%

1.2. Operating Efficiency of CSPC Pharmaceutical Group Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cspc is operating .

  • Measures how much profit Cspc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 22.2% means the company generated $0.22  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 22.2%. The company is operating efficient. +1
  • The TTM is 22.2%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ22.2%TTM22.2%0.0%
TTM22.2%YOY21.9%+0.3%
TTM22.2%5Y21.7%+0.5%
5Y21.7%10Y20.9%+0.8%
1.2.2. Operating Ratio

Measures how efficient Cspc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.78 means that the operating costs are $0.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 0.778. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.778. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.778TTM0.7780.000
TTM0.778YOY0.781-0.003
TTM0.7785Y0.783-0.005
5Y0.78310Y1.031-0.248

1.3. Liquidity of CSPC Pharmaceutical Group Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cspc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.63 means the company has $2.63 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 2.627. The company is able to pay all its short-term debts. +1
  • The TTM is 2.627. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.627TTM2.6270.000
TTM2.627YOY2.674-0.048
TTM2.6275Y2.568+0.059
5Y2.56810Y2.320+0.247
1.3.2. Quick Ratio

Measures if Cspc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 2.38 means the company can pay off $2.38 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 2.379. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.379. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.379TTM2.3790.000
TTM2.379YOY2.711-0.332
TTM2.3795Y2.428-0.049
5Y2.42810Y1.638+0.789

1.4. Solvency of CSPC Pharmaceutical Group Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cspc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cspc to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.24 means that Cspc assets are financed with 24.3% credit (debt) and the remaining percentage (100% - 24.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 0.243. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.243. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.243TTM0.2430.000
TTM0.243YOY0.236+0.007
TTM0.2435Y0.235+0.008
5Y0.23510Y0.280-0.045
1.4.2. Debt to Equity Ratio

Measures if Cspc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 33.9% means that company has $0.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 0.339. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.339. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.339TTM0.3390.000
TTM0.339YOY0.326+0.013
TTM0.3395Y0.324+0.015
5Y0.32410Y0.406-0.082

2. Market Valuation of CSPC Pharmaceutical Group Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cspc generates.

  • Above 15 is considered overpriced but always compare Cspc to the Drug Manufacturers - General industry mean.
  • A PE ratio of 83.05 means the investor is paying $83.05 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The EOD is 77.855. Based on the earnings, the company is expensive. -2
  • The MRQ is 83.046. Based on the earnings, the company is expensive. -2
  • The TTM is 83.046. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD77.855MRQ83.046-5.190
MRQ83.046TTM83.0460.000
TTM83.046YOY96.199-13.153
TTM83.0465Y42.360+40.686
5Y42.36010Y25.242+17.117
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY112.465-112.465
TTM-5Y82.048-82.048
5Y82.04810Y48.502+33.546
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cspc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.93 means the investor is paying $1.93 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The EOD is 1.809. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.929. Based on the equity, the company is underpriced. +1
  • The TTM is 1.929. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.809MRQ1.929-0.121
MRQ1.929TTM1.9290.000
TTM1.929YOY2.625-0.695
TTM1.9295Y2.154-0.225
5Y2.15410Y1.189+0.966
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of CSPC Pharmaceutical Group Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0300.0300%0.030+1%-0.176+689%-0.022+175%
Book Value Per Share--0.4150.4150%0.385+8%0.338+23%0.634-35%
Current Ratio--2.6272.6270%2.674-2%2.568+2%2.320+13%
Debt To Asset Ratio--0.2430.2430%0.236+3%0.235+3%0.280-13%
Debt To Equity Ratio--0.3390.3390%0.326+4%0.324+5%0.406-17%
Dividend Per Share----0%0.004-100%0.002-100%0.005-100%
Eps--0.0100.0100%0.010-8%0.037-74%0.031-69%
Gross Profit Margin--1.0001.0000%-10.400+1140%-6.200+720%-2.600+360%
Market Cap8927400192.000-7%9522560204.8009522560204.8000%12037708230.000-21%9141744242.960+4%6298088405.465+51%
Net Profit Margin--0.1870.1870%0.197-5%0.192-3%0.174+7%
Operating Margin--0.2220.2220%0.219+1%0.217+3%0.209+7%
Operating Ratio--0.7780.7780%0.7810%0.783-1%1.031-25%
Pb Ratio1.809-7%1.9291.9290%2.625-26%2.154-10%1.189+62%
Pe Ratio77.855-7%83.04683.0460%96.199-14%42.360+96%25.242+229%
Price Per Share0.750-7%0.8000.8000%1.010-21%0.766+4%0.527+52%
Price To Free Cash Flow Ratio----0%112.465-100%82.048-100%48.502-100%
Price To Total Gains Ratio25.110-7%26.78426.7840%30.499-12%22.440+19%19.210+39%
Quick Ratio--2.3792.3790%2.711-12%2.428-2%1.638+45%
Return On Assets--0.0180.0180%0.021-16%0.021-14%0.019-9%
Return On Equity--0.0240.0240%0.029-15%0.028-13%0.028-11%
Total Gains Per Share--0.0300.0300%0.033-10%-0.174+682%-0.018+159%
Usd Book Value--4936198935.0004936198935.0000%4586567639.000+8%4033148125.600+22%7569454566.266-35%
Usd Book Value Change Per Share--0.0300.0300%0.030+1%-0.176+689%-0.022+175%
Usd Book Value Per Share--0.4150.4150%0.385+8%0.338+23%0.634-35%
Usd Dividend Per Share----0%0.004-100%0.002-100%0.005-100%
Usd Eps--0.0100.0100%0.010-8%0.037-74%0.031-69%
Usd Free Cash Flow----0%107035114.260-100%62718657.091-100%78309454.935-100%
Usd Market Cap8927400192.000-7%9522560204.8009522560204.8000%12037708230.000-21%9141744242.960+4%6298088405.465+51%
Usd Price Per Share0.750-7%0.8000.8000%1.010-21%0.766+4%0.527+52%
Usd Profit--114666446.916114666446.9160%125133507.486-8%107423969.225+7%205575613.471-44%
Usd Revenue--614008633.374614008633.3740%635527081.704-3%557313562.681+10%1226265709.602-50%
Usd Total Gains Per Share--0.0300.0300%0.033-10%-0.174+682%-0.018+159%
 EOD+3 -4MRQTTM+0 -0YOY+12 -205Y+19 -1310Y+17 -15

3.2. Fundamental Score

Let's check the fundamental score of CSPC Pharmaceutical Group Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1577.855
Price to Book Ratio (EOD)Between0-11.809
Net Profit Margin (MRQ)Greater than00.187
Operating Margin (MRQ)Greater than00.222
Quick Ratio (MRQ)Greater than12.379
Current Ratio (MRQ)Greater than12.627
Debt to Asset Ratio (MRQ)Less than10.243
Debt to Equity Ratio (MRQ)Less than10.339
Return on Equity (MRQ)Greater than0.150.024
Return on Assets (MRQ)Greater than0.050.018
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of CSPC Pharmaceutical Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than502.755
Ma 20Greater thanMa 500.762
Ma 50Greater thanMa 1000.789
Ma 100Greater thanMa 2000.798
OpenGreater thanClose0.750
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Stockholders Equity  -14,457-942-15,3991,972-13,4271,396-12,0313,156,0123,143,981



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets6,524,014
Total Liabilities1,587,815
Total Stockholder Equity4,680,381
 As reported
Total Liabilities 1,587,815
Total Stockholder Equity+ 4,680,381
Total Assets = 6,524,014

Assets

Total Assets6,524,014
Total Current Assets3,770,013
Long-term Assets2,754,001
Total Current Assets
Cash And Cash Equivalents 1,693,686
Short-term Investments 151,823
Net Receivables 1,416,878
Inventory 442,431
Other Current Assets 65,194
Total Current Assets  (as reported)3,770,013
Total Current Assets  (calculated)3,770,013
+/- 0
Long-term Assets
Property Plant Equipment 1,728,468
Goodwill 33,112
Long-term Assets Other 309,911
Long-term Assets  (as reported)2,754,001
Long-term Assets  (calculated)2,071,492
+/- 682,509

Liabilities & Shareholders' Equity

Total Current Liabilities1,435,353
Long-term Liabilities152,462
Total Stockholder Equity4,680,381
Total Current Liabilities
Short-term Debt 84,555
Accounts payable 400,576
Other Current Liabilities 904,239
Total Current Liabilities  (as reported)1,435,353
Total Current Liabilities  (calculated)1,389,371
+/- 45,982
Long-term Liabilities
Long-term Liabilities  (as reported)152,462
Long-term Liabilities  (calculated)0
+/- 152,462
Total Stockholder Equity
Common Stock1,536,400
Other Stockholders Equity 3,143,981
Total Stockholder Equity (as reported)4,680,381
Total Stockholder Equity (calculated)4,680,381
+/-0
Other
Cash and Short Term Investments 1,845,510
Common Stock Shares Outstanding 11,873,031
Current Deferred Revenue45,982
Liabilities and Stockholders Equity 6,524,014
Net Debt -1,594,040
Short Long Term Debt Total 99,646



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
12,200,547
12,501,230
13,539,851
14,760,186
18,001,216
23,170,820
3,778,274
4,598,031
5,449,541
6,003,232
6,524,014
6,524,0146,003,2325,449,5414,598,0313,778,27423,170,82018,001,21614,760,18613,539,85112,501,23012,200,547
   > Total Current Assets 
6,372,773
6,605,746
7,647,539
8,427,618
13,634,724
13,803,488
1,966,343
2,434,534
3,189,971
3,443,169
3,770,013
3,770,0133,443,1693,189,9712,434,5341,966,34313,803,48813,634,7248,427,6187,647,5396,605,7466,372,773
       Cash And Cash Equivalents 
1,187,751
1,468,421
2,299,468
3,234,678
4,376,937
4,327,020
617,961
1,115,635
1,456,226
1,480,049
1,693,686
1,693,6861,480,0491,456,2261,115,635617,9614,327,0204,376,9373,234,6782,299,4681,468,4211,187,751
       Short-term Investments 
0
0
0
0
1,100,094
2,288,264
263,964
234,748
226,413
513,786
151,823
151,823513,786226,413234,748263,9642,288,2641,100,0940000
       Net Receivables 
3,070,427
3,033,958
3,267,653
3,037,673
3,904,414
3,887,338
655,382
746,046
1,058,516
982,513
1,416,878
1,416,878982,5131,058,516746,046655,3823,887,3383,904,4143,037,6733,267,6533,033,9583,070,427
       Inventory 
1,855,188
1,805,749
1,819,228
2,083,732
3,103,280
3,188,385
364,033
284,575
389,069
367,190
442,431
442,431367,190389,069284,575364,0333,188,3853,103,2802,083,7321,819,2281,805,7491,855,188
       Other Current Assets 
258,969
296,915
260,584
71,014
933,720
1,434,779
65,004
53,530
59,746
99,631
65,194
65,19499,63159,74653,53065,0041,434,779933,72071,014260,584296,915258,969
   > Long-term Assets 
0
0
0
0
6,607,944
9,394,692
1,811,931
2,163,497
2,259,570
2,560,063
2,754,001
2,754,0012,560,0632,259,5702,163,4971,811,9319,394,6926,607,9440000
       Property Plant Equipment 
4,961,171
5,049,087
5,142,767
5,415,032
6,662,523
6,692,220
1,332,584
1,366,149
1,500,190
1,577,624
1,728,468
1,728,4681,577,6241,500,1901,366,1491,332,5846,692,2206,662,5235,415,0325,142,7675,049,0874,961,171
       Goodwill 
128,438
125,060
119,388
111,785
101,723
140,474
27,128
22,934
23,526
33,761
33,112
33,11233,76123,52622,93427,128140,474101,723111,785119,388125,060128,438
       Long Term Investments 
19,743
76,604
27,586
171,821
426,720
907,435
0
0
0
0
0
00000907,435426,720171,82127,58676,60419,743
       Intangible Assets 
96,256
84,122
69,880
60,449
86,215
805,387
190,164
100,726
96,914
307,998
0
0307,99896,914100,726190,164805,38786,21560,44969,88084,12296,256
       Long-term Assets Other 
0
0
0
0
0
0
22,168
54,340
65,863
80,724
309,911
309,91180,72465,86354,34022,168000000
> Total Liabilities 
4,603,747
4,349,702
4,727,244
4,568,864
5,126,687
7,672,001
954,021
1,026,815
1,202,036
1,416,664
1,587,815
1,587,8151,416,6641,202,0361,026,815954,0217,672,0015,126,6874,568,8644,727,2444,349,7024,603,747
   > Total Current Liabilities 
3,838,451
3,602,496
3,484,261
4,084,655
5,759,897
7,247,017
895,355
963,614
1,133,472
1,287,461
1,435,353
1,435,3531,287,4611,133,472963,614895,3557,247,0175,759,8974,084,6553,484,2613,602,4963,838,451
       Short-term Debt 
1,340,066
624,070
0
0
0
0
13,959
34,227
6,027
42,478
84,555
84,55542,4786,02734,22713,9590000624,0701,340,066
       Short Long Term Debt 
1,340,066
624,070
451,966
897,777
774,843
70,449
23,000
99,000
0
153,484
0
0153,484099,00023,00070,449774,843897,777451,966624,0701,340,066
       Accounts payable 
1,258,545
1,209,826
1,147,783
1,215,124
1,597,912
3,273,826
204,864
189,848
254,523
288,890
400,576
400,576288,890254,523189,848204,8643,273,8261,597,9121,215,1241,147,7831,209,8261,258,545
       Other Current Liabilities 
1,640,843
1,494,134
1,443,482
1,580,800
2,443,087
2,477,545
604,213
643,864
805,723
841,193
904,239
904,239841,193805,723643,864604,2132,477,5452,443,0871,580,8001,443,4821,494,1341,640,843
   > Long-term Liabilities 
0
0
0
0
313,676
439,347
58,666
63,201
68,564
129,203
152,462
152,462129,20368,56463,20158,666439,347313,6760000
       Capital Lease Obligations 
0
0
0
0
0
0
164,535
217,714
94,044
400,110
0
0400,11094,044217,714164,535000000
       Long-term Liabilities Other 
0
0
0
0
153,732
0
0
0
0
0
0
000000153,7320000
       Deferred Long Term Liability 
31,341
27,167
26,200
18,783
14,222
7,022
8,082
14,146
41,983
35,814
0
035,81441,98314,1468,0827,02214,22218,78326,20027,16731,341
> Total Stockholder Equity
7,452,620
8,079,154
8,738,055
10,107,626
12,803,483
15,022,426
2,650,376
3,414,827
4,076,253
4,340,047
4,680,381
4,680,3814,340,0474,076,2533,414,8272,650,37615,022,42612,803,48310,107,6268,738,0558,079,1547,452,620
   Common Stock
558,636
9,819,731
9,835,299
10,569,620
12,922,199
10,899,412
1,564,726
1,666,628
1,709,675
1,566,484
1,536,400
1,536,4001,566,4841,709,6751,666,6281,564,72610,899,41212,922,19910,569,6209,835,2999,819,731558,636
   Retained Earnings 
2,719,171
3,520,886
4,592,153
6,043,700
8,086,677
8,744,937
1,393,236
2,036,965
2,708,964
3,037,692
0
03,037,6922,708,9642,036,9651,393,2368,744,9378,086,6776,043,7004,592,1533,520,8862,719,171
   Accumulated Other Comprehensive Income 0-252,098-328,959-273,367-293,128000000
   Capital Surplus 00000000000
   Treasury Stock00000000000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,449,338
Cost of Revenue-1,311,938
Gross Profit3,137,4003,137,400
 
Operating Income (+$)
Gross Profit3,137,400
Operating Expense-2,147,429
Operating Income989,971989,971
 
Operating Expense (+$)
Research Development683,367
Selling General Administrative10,410,063
Selling And Marketing Expenses-
Operating Expense2,147,42911,093,430
 
Net Interest Income (+$)
Interest Income-
Interest Expense-3,664
Other Finance Cost-23,104
Net Interest Income-26,768
 
Pretax Income (+$)
Operating Income989,971
Net Interest Income-26,768
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,053,063926,878
EBIT - interestExpense = 986,307
1,017,191
834,580
Interest Expense3,664
Earnings Before Interest and Taxes (EBIT)989,9711,056,727
Earnings Before Interest and Taxes (EBITDA)1,147,598
 
After tax Income (+$)
Income Before Tax1,053,063
Tax Provision-1,288,831
Net Income From Continuing Ops6,306,121-235,768
Net Income830,916
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses3,459,367
Total Other Income/Expenses Net63,09326,768
 

Technical Analysis of Cspc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cspc. The general trend of Cspc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cspc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CSPC Pharmaceutical Group Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: < < .

The bearish price targets are: 0.75 > 0.75 > 0.75.

Tweet this
CSPC Pharmaceutical Group Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CSPC Pharmaceutical Group Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CSPC Pharmaceutical Group Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CSPC Pharmaceutical Group Ltd. The current macd is -0.01298606.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cspc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cspc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cspc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
CSPC Pharmaceutical Group Ltd Daily Moving Average Convergence/Divergence (MACD) ChartCSPC Pharmaceutical Group Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CSPC Pharmaceutical Group Ltd. The current adx is 85.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cspc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
CSPC Pharmaceutical Group Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CSPC Pharmaceutical Group Ltd. The current sar is 0.78970686.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CSPC Pharmaceutical Group Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CSPC Pharmaceutical Group Ltd. The current rsi is 2.7548593. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
CSPC Pharmaceutical Group Ltd Daily Relative Strength Index (RSI) ChartCSPC Pharmaceutical Group Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CSPC Pharmaceutical Group Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cspc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
CSPC Pharmaceutical Group Ltd Daily Stochastic Oscillator ChartCSPC Pharmaceutical Group Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CSPC Pharmaceutical Group Ltd. The current cci is -41.66666667.

CSPC Pharmaceutical Group Ltd Daily Commodity Channel Index (CCI) ChartCSPC Pharmaceutical Group Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CSPC Pharmaceutical Group Ltd. The current cmo is -98.43694526.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CSPC Pharmaceutical Group Ltd Daily Chande Momentum Oscillator (CMO) ChartCSPC Pharmaceutical Group Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CSPC Pharmaceutical Group Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
CSPC Pharmaceutical Group Ltd Daily Williams %R ChartCSPC Pharmaceutical Group Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CSPC Pharmaceutical Group Ltd.

CSPC Pharmaceutical Group Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CSPC Pharmaceutical Group Ltd. The current atr is 0.00145613.

CSPC Pharmaceutical Group Ltd Daily Average True Range (ATR) ChartCSPC Pharmaceutical Group Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CSPC Pharmaceutical Group Ltd. The current obv is -35,620.

CSPC Pharmaceutical Group Ltd Daily On-Balance Volume (OBV) ChartCSPC Pharmaceutical Group Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CSPC Pharmaceutical Group Ltd. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
CSPC Pharmaceutical Group Ltd Daily Money Flow Index (MFI) ChartCSPC Pharmaceutical Group Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CSPC Pharmaceutical Group Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

CSPC Pharmaceutical Group Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CSPC Pharmaceutical Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than502.755
Ma 20Greater thanMa 500.762
Ma 50Greater thanMa 1000.789
Ma 100Greater thanMa 2000.798
OpenGreater thanClose0.750
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cspc with someone you think should read this too:
  • Are you bullish or bearish on Cspc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cspc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CSPC Pharmaceutical Group Ltd

I send you an email if I find something interesting about CSPC Pharmaceutical Group Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about CSPC Pharmaceutical Group Ltd.

Receive notifications about CSPC Pharmaceutical Group Ltd in your mailbox!